Cargando…

Dose-Dependent Efficacy of Aripiprazole in Treating Patients With Schizophrenia or Schizoaffective Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Purpose: To compare the efficacy and tolerability of different administration strategies of aripiprazole. Methods: We searched MEDLINE, EMBASE, the Cochrane Central, Web of Science, China National Knowledge Infrastructure(CNKI), and Wanfang Data Knowledge Service Platform(Wanfang) for randomized con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Li, Xuemei, Liao, Jitao, Li, Yun'Ai, Su, Tianmei, Si
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385236/ https://www.ncbi.nlm.nih.gov/pubmed/34456770 http://dx.doi.org/10.3389/fpsyt.2021.717715

Ejemplares similares

Efficacy and tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Andrade, Chittaranjan
Publicado: (2004)

Efficacy and Tolerability of Aripiprazole in Patients with Schizophrenia & Schizoaffective Disorders
por: Chavda, R.K., et al.
Publicado: (2004)

Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China
por: Li, Qian, et al.
Publicado: (2023)

Critical evaluation of paliperidone in the treatment of schizophrenia in Chinese patients: a systematic literature review
por: Zhang, LiLi, et al.
Publicado: (2016)

Dose-dependent rapid-onset akathisia with aripiprazole in patients with schizoaffective disorder
por: Basu, Ranita, et al.
Publicado: (2006)

Postnatal BDNF Expression Profiles in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by MK-801 Administration
por: Guo, Chunmei, et al.
Publicado: (2010)

The recovery of homicidal people diagnosed with schizophrenia and schizoaffective disorder—An interpretative phenomenological analysis
por: Kovács, Asztrik, et al.
Publicado: (2023)

Dose Adjustment Model of Paliperidone in Patients With Acute Schizophrenia: A post hoc Analysis of an Open-Label, Single-Arm Multicenter Study
por: Si, Tianmei, et al.
Publicado: (2021)

Clinical Usefulness of Aripiprazole and Lamotrigine in Schizoaffective Presentation of Tuberous Sclerosis
por: Lee, Seung-Yup, et al.
Publicado: (2016)

Reducing the Diagnostic Heterogeneity of Schizoaffective Disorder
por: Seldin, Katherine, et al.
Publicado: (2017)

Visuospatial and Sensory Integration Tasks in Patients With Schizophrenia or Schizoaffective Disorder: Relationship to Body Mass Index and Smoking
por: Vanderhoof, Tyler S., et al.
Publicado: (2018)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
por: Giordano, Gloria, et al.
Publicado: (2020)

Fundamental Role of Methylenetetrahydrofolate Reductase 677 C → T Genotype and Flavin Compounds in Biochemical Phenotypes for Schizophrenia and Schizoaffective Psychosis
por: Fryar-Williams, Stephanie
Publicado: (2016)

Structural Differences Between Healthy Subjects and Patients With Schizophrenia or Schizoaffective Disorder: A Graph and Control Theoretical Perspective
por: Dimulescu, Cristiana, et al.
Publicado: (2021)

Dose-response analysis of aripiprazole in patients with schizophrenia in Taiwan
por: Tien, Yun, et al.
Publicado: (2022)

Schizoaffective Disorder That Is Induced By Electrical Voltage That Is Treated with Risperidone
por: Fadhilah, Ihsan, et al.
Publicado: (2019)

Electroconvulsive Therapy for Traumatic Brain Injury and Schizoaffective Disorder
por: Adachi, Ryan, et al.
Publicado: (2021)

A Perspective on a Possible Relation Between the Psychopathology of the Schizophrenia/Schizoaffective Spectrum and Unconjugated Bilirubin: A Longitudinal Protocol Study
por: Gama Marques, João, et al.
Publicado: (2018)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

Cognitive Remediation Interventions in Schizoaffective Disorder: A Systematic Review
por: Lopez-Fernandez, Ester, et al.
Publicado: (2018)

Healthcare resource use and costs reduction with aripiprazole once-monthly in schizophrenia: AMBITION, a real-world study
por: Sanchez-Gistau, Vanessa, et al.
Publicado: (2023)

Augmentation of Clozapine with Aripiprazole in Severe Psychotic Bipolar and Schizoaffective Disorders: A Pilot Study
por: Benedetti, Alessandra, et al.
Publicado: (2010)

Assessment of the Minimum Clinically Important Difference in Symptoms and Functions of Patients With Acute Schizophrenia: A Post hoc Analysis of an Open-Label, Single-Arm Multicenter Study
por: Si, Tianmei, et al.
Publicado: (2021)

Differential Behavioral and Neurobiological Effects of Chronic Corticosterone Treatment in Adolescent and Adult Rats
por: Li, Jitao, et al.
Publicado: (2017)

Oedipism and Self-Amputation in a Schizoaffective, Depressed Type Patient: To Heal or Feel Pain?
por: Sangha, Sukhjeet, et al.
Publicado: (2021)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities
por: Liao, Xuemei, et al.
Publicado: (2021)

Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder
por: An, Jing, et al.
Publicado: (2019)

A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting
por: Hsieh, Ming-Hong, et al.
Publicado: (2010)

The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review
por: Muneer, Ather
Publicado: (2016)

Does the Time of Drug Administration Alter the Metabolic Risk of Aripiprazole?
por: Chipchura, Danielle A., et al.
Publicado: (2018)

Retrospective Study of Japanese Patients with Schizophrenia Treated with Aripiprazole
por: Tanioka, Tetsuya, et al.
Publicado: (2012)

Neurophysiological Distinction between Schizophrenia and Schizoaffective Disorder
por: Mathalon, Daniel H., et al.
Publicado: (2010)

Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder
por: Archibald, Luke, et al.
Publicado: (2019)

Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae–Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials
por: Zhang, Ling, et al.
Publicado: (2021)

Hiccups induced by aripiprazole combined with sertraline in an adolescent with olfactory reference disorder: A case report
por: Li, Zhe, et al.
Publicado: (2022)

Deep Venous Thrombosis in a 62-Year-Old Female With Schizoaffective Disorder Who Developed COVID-19
por: Yee, Maria Ruiza, et al.
Publicado: (2020)

Dissociative Amnesia and Dissociative Fugue in a 20-Year-Old Woman With Schizoaffective Disorder and Post-Traumatic Stress Disorder
por: Clouden, Tobechukwu A
Publicado: (2020)

Differences of Fasting Blood Glucose Level in People with Schizophrenia between Before and After Getting Aripiprazole Treatment
por: Turangan, Dahlia Rosally, et al.
Publicado: (2019)

Aripiprazole for late-life schizophrenia
por: Rado, Jeffrey, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4f3sv8g0at12u1iann058dj9m9